文献速递胃肠外科围术期管理与 ERAS

减重手术后出院后药物预防对静脉血栓栓塞的影响:全国性队列研究

To What Extent Does Posthospital Discharge Chemoprophylaxis Prevent Venous Thromboembolism After Bariatric Surgery?: Results From a Nationwide Cohort of More Than 110,000 Patients.
PubMed 文献 · Ann Surg · 2018-01-01

该研究基于法国全国保险数据库2012至2014年110,824例减重手术患者,评估出院后药物预防对静脉血栓栓塞(VTE)的作用。术后30天和90天VTE发生率分别为0.34%和0.51%,未使用出院后药物预防是90天内VTE的独立预测因素(OR 1.27,95%CI 1.01-1.61),在胃旁路组为1.51(1.01-2.29)。

要点

  • 减重术后90天内VTE发生率为0.51%,出院后药物预防使用率75%。
  • 未使用出院后药物预防是VTE独立预测因素(OR 1.27,95%CI 1.01-1.61)。
  • 术后并发症、VTE病史、心衰和开放手术是VTE主要风险因素。

核心结论

  • 未使用出院后药物预防是减重术后90天内VTE的独立预测因素,使用可能降低出院后VTE风险。

研究设计与样本

  • 全国性观察性人群队列研究,数据来自法国国家健康保险数据库(SNIIRAM),纳入2012年1月1日至2014年9月31日(原文如此)接受减重手术的患者共110,824例。

主要发现

  • 56%的患者接受袖状胃切除术;术后30天和90天VTE发生率分别为0.34%和0.51%。
  • 90天内VTE主要风险因素:VTE病史OR=6.33(95%CI 4.44-9.00),术后并发症OR=9.23(95%CI 7.30-11.70),心力衰竭OR=2.45(95%CI 1.48-4.06),开放手术OR=2.38(95%CI 1.59-3.45)。
  • 出院后药物预防(肝素)使用率为75%;未使用出院后药物预防的OR=1.27(95%CI 1.01-1.61),在胃旁路组OR=1.51(95%CI 1.01-2.29)。

临床怎么用

  • 减重手术后应评估个体VTE风险,尤其对存在VTE病史、术后并发症、心衰或开放手术等高危因素的患者考虑出院后药物预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of the present study was to assess the incidence, risk factors, and the impact of posthospital discharge (PHD) chemoprophylaxis on venous thromboembolism (VTE) in patients undergoing bariatric surgery (BS). BACKGROUND: VTE is a major concern after BS, especially during the PHD period. No large-scale study has previously focused on the clinical value of PHD chemoprophylaxis. METHODS: In this nationwide observational population-based cohort study, all data from patients undergoing BS were extracted from the French National Health Insurance database (SNIIRAM) from 1st January 2012 to 31st September 2014. Logistic regression models were used to compute odds ratios for potential risk factors for VTE occurring within 90 postoperative days (PODs). The association between use of PHD chemoprophylaxis (heparin) and VTE was also assessed. RESULTS: The majority (56%) of the 110,824 patients had sleeve gastrectomy. VTE rates during the first 30 and 90 PODs were 0.34% and 0.51%, respectively. On multivariate analyses, the major risk factors for VTE during the first 90 PODs were history of VTE [odds ratio = 6.33 95% confidence interval (4.44-9.00)], postoperative complications [9.23 (7.30-11.70)], heart failure [2.45 (1.48-4.06)], and open surgery [2.38 (1.59-3.45)]. PHD chemoprophylaxis was delivered to 75% of patients. No use of PHD chemoprophylaxis [1.27 (1.01-1.61)] was an independent predictive factor of VTE during the first 90 PODs [in the gastric bypass group: 1.51 (1.01-2.29)). CONCLUSIONS: In the modern era of BS, this nationwide study shows a non-negligible rate of VTE especially after sleeve gastrectomy, depending on the individual risk level. Use of PHD chemoprophylaxis may decrease the risk of PHD VTE.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Thereaux J, Lesuffleur T, Czernichow S, et al. To What Extent Does Posthospital Discharge Chemoprophylaxis Prevent Venous Thromboembolism After Bariatric Surgery?: Results From a Nationwide Cohort of More Than 110,000 Patients. Ann Surg. 2018. PMID: 28475558. doi:10.1097/SLA.0000000000002285

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。